Riled By Schering-Plough Case, Senators Introduce Bill
The move comes in reaction to the U.S. Supreme Court’s refusal to hear the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.
“When big brand-name drug companies pay generic manufacturers to stop generic drugs from reaching pharmacy shelves, consumers lose big-time,” said Sen. Herb Kohl (D-Wis.). “These companies are playing it fast-and-loose...
To view the full article, register now.